KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Common Equity: 2009-2024

Historic Common Equity for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $26.5 billion.

  • Cme Group's Common Equity fell 0.09% to $28.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 billion, marking a year-over-year decrease of 0.09%. This contributed to the annual value of $26.5 billion for FY2024, which is 0.94% down from last year.
  • As of FY2024, Cme Group's Common Equity stood at $26.5 billion, which was down 0.94% from $26.7 billion recorded in FY2023.
  • In the past 5 years, Cme Group's Common Equity registered a high of $27.4 billion during FY2021, and its lowest value of $26.3 billion during FY2020.
  • Over the past 3 years, Cme Group's median Common Equity value was $26.7 billion (recorded in 2023), while the average stood at $26.7 billion.
  • As far as peak fluctuations go, Cme Group's Common Equity climbed by 4.10% in 2021, and later fell by 1.90% in 2022.
  • Cme Group's Common Equity (Yearly) stood at $26.3 billion in 2020, then increased by 4.10% to $27.4 billion in 2021, then declined by 1.90% to $26.9 billion in 2022, then dropped by 0.52% to $26.7 billion in 2023, then declined by 0.94% to $26.5 billion in 2024.